Amniotic fluid metabolomic analysis in spontaneous preterm birth

Reproductive Sciences

Volumn 21, Issue 6, 2014, Pages 791-803

  Menon, Ramkumar ^a   Jones, Janice ^b   Gunst, Phillip R ^b   Kacerovsky, Marian ^c,d   Fortunato, Stephen J ^c,d   Saade, George R ^a   Basraon, Sanmaan ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b METABOLON INC   (United States)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

African Americans; liver functions; OMICs; pregnancy; prematurity

Indexed keywords

BILE ACID; COENZYME A; CYTOCHROME P450; DEXPANTHENOL; FATTY ACID; HEME; HISTIDINE; STEROID; XANTHINE DERIVATIVE;

ADULT; AFRICAN AMERICAN; AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; ETHNIC DIFFERENCE; FATTY ACID METABOLISM; FEMALE; GESTATIONAL AGE; HUMAN; LIQUID CHROMATOGRAPHY; LIVER FUNCTION; LIVER METABOLISM; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; PREMATURE LABOR; PRIORITY JOURNAL; AMNION FLUID; MALE; METABOLISM; NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH; PROCEDURES;

AMNIOTIC FLUID; FEMALE; HUMANS; INFANT, NEWBORN; MALE; METABOLOMICS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREMATURE BIRTH;

EID: 84900431163     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113518987     Document Type: Article

References (40)

1. Menon R, Torloni MR, Voltolini C, et al. Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reprod Sci. 2011 ; 18 (11). 1046-1070
2. Bastek JA, Elovitz MA. The role and challenges of biomarkers in spontaneous preterm birth and preeclampsia. Fertil Steril. 2013 ; 99 (4). 1117-1123
3. Conde-Agudelo A, Romero R. Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2010 ; 23 (12). 1365-1376
4. Conde Agudelo A, Papageorghiou AT, Kennedy SH, Villar J. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG. 2011 ; 118 (9). 1042-1054
5. Goldenberg RL, Andrews WW. Intrauterine infection and why preterm prevention programs have failed. Am J Public Health. 1996 ; 86 (6). 781-783
6. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 ; 371 (9606). 75-84
7. Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG. 2006 ; 113 (suppl 3). 17-42
8. Bastek JA, Gomez LM, Elovitz MA. The role of inflammation and infection in preterm birth. Clin Perinatol. 2011 ; 38 (3). 385-406
9. Elovitz MA. Anti-inflammatory interventions in pregnancy: now and the future. Semin Fetal Neonatal Med. 2006 ; 11 (5). 327-332
10. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med. 2007 ; 25 (1). 21-39
11. Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P, Fairclough L. Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen. 2010 ; 15 (5). 562-568
12. Kramer MS, Kahn SR, Platt RW, et al. Mid-trimester maternal plasma cytokines and CRP as predictors of spontaneous preterm birth. Cytokine. 2010 ; 49 (1). 10-14
13. Riedmaier I, Pfaffl MW. Transcriptional biomarkers - high throughput screening, quantitative verification, and bioinformatical validation methods. Methods. 2013 ; 59 (1). 3-9
14. Buhimschi IA, Buhimschi CS, Weiner CP, et al. Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form. Clin Diagn Lab Immunol. 2005 ; 12 (7). 837-844
15. Cobo T, Palacio M, Navarro Sastre A, et al. Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranes. Am J Obstet Gynecol. 2009 ; 200 (5). 499-496
16. Crawford JT, Pereira L, Buckmaster J, Gravett MG, Tolosa JE. Amniocentesis results and novel proteomic analysis in a case of occult candidal chorioamnionitis. J Matern Fetal Neonatal Med. 2006 ; 19 (10). 667-670
17. Gravett MG, Novy MJ, Rosenfeld RG, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004 ; 292 (4). 462-469
18. Gravett MG, Thomas A, Schneider KA, et al. Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res. 2007 ; 6 (1). 89-96
19. Hitti J, Lapidus JA, Lu X, et al. Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid. Am J Obstet Gynecol. 2010 ; 203 (1). 32-38
20. Tambor V, Kacerovsky M, Lenco J, Bhat G, Menon R. Proteomics and bioinformatics analysis reveal underlying pathways of infection associated histologic chorioamnionitis in pPROM. Placenta. 2013 ; 34 (2). 155-161
21. Romero R, Espinoza J, Gotsch F, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG. 2006 ; 113 (suppl 3). 118-135
22. Romero R, Mazaki Tovi S, Vaisbuch E, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med. 2010 ; 23 (12). 1344-1359
23. Gracie S, Pennell C, Ekman Ordeberg G, et al. An integrated systems biology approach to the study of preterm birth using "-omic" technology - a guideline for research. BMC Pregnancy Childbirth. 2011 ; 11: 71
24. Johnsrud EK, Koukouritaki SB, Divakaran K, Brunengraber LL, Hines RN, McCarver DG. Human hepatic CYP2E1 expression during development. J Pharmacol Exp Ther. 2003 ; 307 (1). 402-407
25. Pacifici GM, Rane A. Metabolism of styrene oxide in different human fetal tissues. Drug Metab Dispos. 1982 ; 10 (4). 302-305
26. Adjei AA, Gaedigk A, Simon SD, Weinshilboum RM, Leeder JS. Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects. Birth Defects Res A Clin Mol Teratol. 2008 ; 82 (3). 155-165
27. Hukkanen J, Mantyla M, Kangas L, et al. Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium. Pharmacol Toxicol. 1998 ; 82 (2). 93-97
28. Tuckey RC. Progesterone synthesis by the human placenta. Placenta. 2005 ; 26 (4). 273-281
29. Rabe T, Kalbfleisch H, Haun A, Runnebaum B. Influence of human lipoproteins on the progesterone synthesis of human term placenta in organ culture. Biol Res Pregnancy Perinatol. 1983 ; 4 (2). 75-83
30. Hellig H, Gattereau D, Lefebvre Y, Bolte E. Steroid production from plasma cholesterol. I. Conversion of plasma cholesterol to placental progesterone in humans. J Clin Endocrinol Metab. 1970 ; 30 (5). 624-631
31. Smith R, Nicholson RC. Corticotrophin releasing hormone and the timing of birth. Front Biosci. 2007 ; 12: 912-918
32. Challis JR. CRH, a placental clock and preterm labour. Nat Med. 1995 ; 1 (5). 416
33. Pathak B, Sheibani L, Lee RH. Cholestasis of pregnancy. Obstet Gynecol Clin North Am. 2010 ; 37 (2). 269-282
34. Coletta J, Simpson LL. Maternal medical disease and stillbirth. Clin Obstet Gynecol. 2010 ; 53 (3). 607-616
35. Simpson LL. Maternal medical disease: risk of antepartum fetal death. Semin Perinatol. 2002 ; 26 (1). 42-50
36. Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol. 1988 ; 95 (11). 1137-1143
37. Dunlop AL, Taylor RN, Tangpricha V, Fortunato S, Menon R. Maternal micronutrient status and preterm versus term birth for black and white US women. Reprod Sci. 2012 ; 19 (9). 939-948
38. Mozurkewich EL, Klemens C. Omega-3 fatty acids and pregnancy: current implications for practice. Curr Opin Obstet Gynecol. 2012 ; 24 (2). 72-77
39. Jordan RG. Prenatal omega-3 fatty acids: review and recommendations. J Midwifery Womens Health. 2010 ; 55 (6). 520-528
40. Abiko Y.. Investigations on pantothenic acid and its related compounds. IX. Biochemical studies. 4. Separation and substrate specificity of pantothenate kinase and phosphopantothenoylcysteine synthetase. J Biochem. 1967 ; 61 (3). 290-299